Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Don't forget about the testing being done with the Army. That's overlooked
Great video. Active discussions with the FDA already Linda says.. Scroll about minutes into it. Posted online a couple days ago.
https://www.ytaclub.com/tv/Featured-Shows/The-Big-Biz-Show/video/5e0281554a533917c26f31f92f3ce8f9
This should be heading north. Covid still progressing. Good news here from IPIX.. Bought a ton this morning at open.
Innovation Pharmaceuticals' Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
Innovation Pharmaceuticals' Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
CTSI Translational Tuesdays - Development of Heat Shock Protein Vaccine for COVID-19 with Dr. Natasa Strbo
Description
Please join us for a virtual presentation and Q&A with Dr. Natasa Strbo, who will provide a timely overview on efforts to develop a vaccine for the 2019 novel coronavirus SARS-CoV-2, the causative agent of coronavirus disease (COVID-19) including development of cell-based heat shock protein vaccine, at the Miller School of Medicine's Department of Microbiology and Immunology.
https://zoom.us/webinar/register/WN_tWhQNIoHSQWr2DHxN5A4Bg
Nice consolidation here today. Good news to follow. Watch webinar at 5pm EST. Link below. Then ASCO end of month. Good things are coming!
https://zoom.us/webinar/register/WN_tWhQNIoHSQWr2DHxN5A4Bg
Do your DD. It's not JUST a Corona stock...
New tweet out again today. Just updating progress on their website. No delisting for any company below $1 until end of December now. So good news on the extension anyway.
Company isn't half bad, has decent pipeline besides Covid test/vaccine, but their PR sucks... They're so slow to update shareholders it's pathetic. Major release of some sort may help this one out. I'm really in this for their phase 2 cancer treatment update.
News out! Good stuff and worth reading.
https://charts.stocktwits.com/production/original_209213578.png
Over 1 million shares already traded pre-market.. Someone believes in the patent they are filing.
Supposed to be a PR at 9am I think too...
Heat Biologics, Inc. (the “Company”) has terminated its collaboration with the University of Miami for the development of a COVID-19 point of care diagnostic. The Company has also filed a provisional patent application for its own COVID-19 diagnostic test.
I'm curious as to which Congressmen DECN spoke with, per their press release today. That's something that should be public knowledge and would maybe help their credibility claim as we can then solicit those Congressmen for confirmation of the conversation that supposedly took place..
I haven't checked if any of them have an EUA number associated. There's just too many to go through.
Some more info...
On April 13, the SEC halted trading in the shares of Aarayit Corp (https://www.sec.gov/litigation/suspensions/2020/34-88623-o.pdf).(ARYC), a Nevada corporation with its main business operation in Sunnyvale, California for claiming it had an approved COVID-19 blood test.
That same day, the regulator halted trading of the shares of Applied BioSciences Corp (https://www.sec.gov/litigation/suspensions/2020/34-88627-o.pdf).(APPB) over claims made regarding the sale of COVID-19 home testing kits. A similar claim made on a cable new program by the chief executive of Florida-based Solei Systems Inc. (https://www.sec.gov/litigation/suspensions/2020/34-88620-o.pdf)(SOLI) led to that stock being halted on April 10. The SEC also halted the stock of Parallax Health Sciences Inc (https://www.sec.gov/litigation/suspensions/2020/34-88618-o.pdf).(PRLX) (https://www.sec.gov/litigation/suspensions/2020/34-88618-o.pdf)for claims relating to a rapid screening test and large quantities of diagnostic kits and personal protective equipment, all of which are greatly in demand.
Just be aware of this so you don't caught with your pants down... Just posted online.
The Securities and Exchange Commission has taken enforcement action against 23 companies in connection with statements made relating to COVID-19 and is warning investors to beware of fraud, illicit schemes and other misconduct during the pandemic.
The latest moves came Wednesday, when the SEC halted trading of Salt Lake City, Utah-based Predictive Technology Group Inc (https://www.sec.gov/litigation/suspensions/2020/34-88719.pdf?mod=article_inline).(PRED) and New York-based SCWorx (https://www.sec.gov/litigation/suspensions/2020/34-88712.pdf?mod=article_inline) Corp (https://www.sec.gov/litigation/suspensions/2020/34-88712.pdf?mod=article_inline).(WORX) over questions regarding the accuracy of public information about their plans to sell COVID-19 tests.
"The Enforcement Division is committing substantial resources to ensuring that our Main Street investors are not victims of fraud or illegal practices in these unprecedented market and economic conditions," the SEC said in a March 23 statement. (https://www.sec.gov/news/public-statement/statement-enforcement-co-directors-market-integrity)
Many small biotech companies and microcaps that trade over the counter are not obliged to make the same financial disclosures as bigger companies. But some have seen their stocks soar on hopes they will be able to cash in on the need for testing and treatments for the pandemic, which has infected 2.67 million people worldwide and caused 186,131 fatalities, according to data aggregated by Johns Hopkins University. (https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6?mod=article_inline&mod=article_inline&mod=article_inline&mod=article_inline&mod=article_inline&mod=article_inline&mod=article_inline)
In February when the virus was beginning to hit the headlines in the U.S., the SEC warned of the possible emergence of fraudsters (https://www.sec.gov/oiea/investor-alerts-and-bulletins/ia_coronavirus), who would use the news to lure investors into scams. The regulator highlighted the proliferation of internet promotions, often using social media, claiming products or services that could prevent, detect or cure the virus, and that would lead those companies' stocks to rise dramatically as a result.
Just as happened at the height of the mania around cryptocurrency (http://www.marketwatch.com/story/crypto-is-an-unregulated-casino-where-criminality-runs-riot-2019-07-16) and later cannabis (http://www.marketwatch.com/story/the-collapse-of-this-cannabis-shock-offers-a-valuable-lesson-to-every-investor-2018-11-23), COVID-19 promotions often appear in the guise of "research reports" while actually being pump-and-dump schemes, said the SEC.
"We urge investors to be wary of these promotions, and to be aware of the substantial potential for fraud at this time,' said the statement.
Should be more good news coming soon.. Phase 2 about done. Excellent results in phase 1.
gp96 + CTAs
(Cell Therapy)
Some good news..
https://www.businesswire.com/news/home/20200413005104/en/
Yep. I've worked for a world wide major healthcare company for over 20 years. We're a major competitor to Abbott. We'll be releasing our test in the next 6-8 weeks hopefully. It too though is serum based and run on a system in a lab. If Heat pulls this off soon, we'll be doing well and helping people quickly.
Encouraging news here. Rawman specifically, have you reviewed this article about the Korean workers and DECN testing. The finger stick test kit utilizes your own bodies antibodies and antigens for a definitive result. Pretty clear...
https://apnews.com/ACCESSWIRE/a8834c839cd6d19f7bbaaf34055b6fff
DECN announces that the company, through its advanced development team in Korea, has arrived at a second Covid-19 test methodology, a modified Serology method, that at the completion of documentation, be put through the FDA Emergency Waiver (EUA) process. This second kit will begin assembly for internal testing on April 1, with availability in late summer 2020. The method will again use a Biosensor (test strip-like device) and the company’s Precise meter.
Been a member here for years, but something happened to my account and I had to re-register. I have my doubts about the remainder in the pipeline. My thoughts are that we see $8 at best next year. We are supposed to see 2 early data reviews this year and one in 2017. Going to be a slow road for sure. I've been flipping in and out, but not enough to cover my core. So I ended up taking a hit on the drop.. Good luck everyone.
maybe there's a hedgie who received some notice of poor data? Depressing to say the least. I have been buying and selling with the peaks and valleys, but it's getting old now. Whole sector down again today. Keeping the chin up and hoping for some golden nugget to come along!
CLDX: New SEC Filing for CLDX:
Form SC 13G, No. 0001445546-16-006494
http://stks.co/e3CkV